Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma at High Risk (aa-IPI 2-3). Mature Results of a Multicenter Prospective Phase II Trial

Alessandro Re, MD, Chiara Cattaneo, MD, Salvatore Casari, MD, Guido Gini, MD, Mariagrazia Michieli, Bernardino Allione, Luisa Verga, MD, Caterina Bocci, Michele Spina, MD, Stefania Tamiazzo, Alessandra Bandera, Flavia Salvi, MD, Annalisa Peli, MD, Moira Micheletti, Camillo Almici, MD, Pierino Ferremi, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2014) 124 (21): 2528.

https://doi.org/10.1182/blood.V124.21.2528.2528

Published: 2014

Journal Articles

ARL-IPI - A New Prognostic Score for AIDS-Related Lymphomas in the Rituximab Era

Stefan K Barta, MD, MS, MRCP, Xiaonan Xue, Ph.D., Dan Wang, MS, Jeannette Y Lee, Ph.D., Lawrence D. Kaplan, MD, Josep-Maria Ribera, MD, PhD, Albert Oriol, Olga Garcia, Mireia Morgades, Michele Spina, MD, Umberto Tirelli, MD, Francois Boue, MD, PhD, Wyndham H. Wilson, MD, PhD, Christoph Wyen, MD, Kieron Dunleavy, MD, Joseph A Sparano, MD

Blood (2012) 120 (21): 1564.

https://doi.org/10.1182/blood.V120.21.1564.1564

Published: 2012

Journal Articles

A Pooled Analysis of 1,546 Patients with HIV-Associated Lymphoma: Assessment of Lymphoma-, HIV-, and Treatment-Specific Factors On Clinical Outcomes

Blood (2012) 120 (21): 3682.

https://doi.org/10.1182/blood.V120.21.3682.3682

Published: 2012

Journal Articles

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma At High Risk (Aaipi 2–3). an Interim Report of a Multicenter Phase II Trial.

Alessandro Re, MD, Mariagrazia Michieli, Bernardino Allione, MD, Salvatore Casari, MD, Chiara Cattaneo, MD, Michele Spina, Andrea Gori, Elisa Garlassi, Luisa Verga, MD, Camillo Almici, MD, Pierino Ferremi, Mario Mazzucato, Alessandro Levis, MD, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2012) 120 (21): 3124.

https://doi.org/10.1182/blood.V120.21.3124.3124

Published: 2012

Journal Articles

Safety and Activity of Intensive Short-Term Chemoimmunotherapy in HIV-Positive (HIV+) Patients (pts) with Burkitt Lymphoma (BL)

Marta Bruno Ventre, MD, Giovanni Donadoni, MD, Alessandro Re, MD, Michele Spina, MD, Chiara Cattaneo, Luca Fumagalli, MD, Silvia Mappa, MD, Silvia Govi, MD, Giuseppe Rossi, MD, Umberto Tirelli, MD, Andrés JM Ferreri, MD

Blood (2011) 118 (21): 2692.

https://doi.org/10.1182/blood.V118.21.2692.2692

Published: 2011

Journal Articles

HAART Does Not Improve the Outcome of HIV-Related Multicentric Castleman Disease: Results of a Multicentric Retrospective Study

Chiara Cattaneo, Emanuela Vaccher, Alessandro Re, MD, Salvatore Casari, Erika Borlenghi, Michele Spina, MD, Umberto Tirelli, MD, Giuseppe Rossi

Blood (2011) 118 (21): 4918.

https://doi.org/10.1182/blood.V118.21.4918.4918

Published: 2011

Journal Articles

Comprehensive Geriatric Assessment-Adapted Chemotherapy in Elderly Patients (>70 years) with Diffuse Large B-Cell Non-Hodgkin's Lymphoma (DLBCL): Final Results and Long Term Follow-up.

Umberto Tirelli, MD, Lucia Fratino, Monica Balzarotti, Lilj Uziel, Annalisa Giacalone, Andres Ferreri, Armando Santoro, Michele Spina, MD

Blood (2009) 114 (22): 2684.

https://doi.org/10.1182/blood.V114.22.2684.2684

Published: 2009

Journal Articles

Pretransplatation PET as Major Prognostic Discriminant in IGEV (ifosfamide, gemcitabine, vinorelbine and prednisone) Treated Patients with Relapsed/Refractory Hodgkin's Lymphoma (HL).

Rita Mazza, MD, Stefano Luminari, Massimo Magagnoli, MD, Michele Spina, MD, Teodoro Chisesi, MD, Antonio Pinto, MD, Massimo Federico, MD, Antonella Anastasia, MD, Arturo Chiti, MD, Mariagrazia Michieli, MD, Francesco Angrilli, MD, Luca Castagna, Giampaolo Marcacci, Laura Giordano, PhD, Umberto Tirelli, MD, Armando Santoro, Monica Balzarotti

Blood (2009) 114 (22): 3707.

https://doi.org/10.1182/blood.V114.22.3707.3707

Published: 2009

Journal Articles

Better Outcome with Tandem High DOSE CHEMOTHERAPY and AUTOLOGOUS STEM CELLS TRANSPLANT IN Relapsed/Refractory HODGKIN LYMPHOMA PATIENTS Which Reached COMPLETE REMISSION AFTER Ifosfamide- Gemcitabine-Vinorelbine Scheme (IGEV).

Antonella Anastasia, MD, Monica Balzarotti, Massimo Magagnoli, MD, Michele Spina, MD, Rita Mazza, MD, L. Castagna, Andrea Nozza, Stefania Bramanti, md, Laura Giordano, PhD, Umberto Tirelli, MD, Armando Santoro

Blood (2009) 114 (22): 1213.

https://doi.org/10.1182/blood.V114.22.1213.1213

Published: 2009

Journal Articles

Intensified CHOP (ICHOP) +/− Rituximab in Primary Mediastinal Diffuse Large B Cell Lymphoma (PMBCL): The Role of Doxorubicin/Cyclophosphamide Dose-Intensity

Rita Mazza, MD, Monica Demarco, MD, Michele Spina, MD, Massimo Magagnoli, MD, Luca Castagna, MD, Licia Siracusano, MD, Laura Giordano, PhD, Umberto Tirelli, MD, Armando Santoro, MD, Monica Balzarotti, MD

Blood (2008) 112 (11): 3593.

https://doi.org/10.1182/blood.V112.11.3593.3593

Published: 2008

Journal Articles

High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation as Salvage Therapy for HIV-Associated Lymphoma: Result of the GICAT Study.

Alessandro Re, MD, Mariagrazia Michieli, MD, Chiara Cattaneo, MD, Maurizio Rupolo, MD, Salvatore Casari, MD, Michele Spina, MD, Bernardino Allione, MD, Camillo Almici, MD, Piero Ferremi, MD, Luciano Abruzzese, MD, Cecilia Simonelli, MD, Rosa Manuele, MD, Alessandro Levis, MD, Giampiero Carosi, MD, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2007) 110 (11): 23.

https://doi.org/10.1182/blood.V110.11.23.23

Published: 2007

Journal Articles

Factors Affecting Outcome of Patients with Refractory/Relapsed Hodgkin’s Disease (HD) Treated with IGEV Chemotherapy (CT) and High Dose Consolidation Therapy (HDT) with Stem Cell Rescue.

Monica Balzarotti, MD, Michele Spina, MD, Massimo Magagnoli, MD, Teodoro Chisesi, MD, Antonello Pinto, MD, Luca Castagna, MD, Monica Demarco, MD, Mariagrazia Michieli, MD, Andrea Nozza, MD, Umberto Tirelli, MD, Armando Santoro, MD

Blood (2005) 106 (11): 2091.

https://doi.org/10.1182/blood.V106.11.2091.2091

Published: 2005

Journal Articles

Tymic Output after Autologous Bone Marrow Transplantation (ASCT) HIV-Related Lymphoma.

Cecilia Simonelli, MD, Michele Spina, MD, Chiara Pratesi, ScD, Rosamaria Tedeschi, ScD, Maurizio Rupolo, MD, Maria Teresa Bortolin, ScD, Stefania Zanussi, ScD, Mariagrazia Michieli, MD, Paolo De Paoli, MD, Umberto Tirelli, MD

Blood (2005) 106 (11): 2933.

https://doi.org/10.1182/blood.V106.11.2933.2933

Published: 2005

Journal Articles

VEBEP Regimen and Highly Active Antiretroviral Therapy (HAART) in Patients (pts) with HD and HIV Infection (HD-HIV).

Michele Spina, MD, Giuseppe Rossi, MD, Andrea Antinori, MD, Bernardino Allione, MD, Marco Fasan, MD, Giuliano Rizzardini, MD, Umberto Tirelli, MD

Blood (2005) 106 (11): 329.

https://doi.org/10.1182/blood.V106.11.329.329

Published: 2005

Journal Articles

HIV-Related Burkitt’s NHL (BL) vs. Diffuse Large-Cell NHL (DLCL) in the Pre- and HAART Eras: Significant Differences in Survival with Standard Chemotherapy.

Michele Spina, MD, Cecilia Simonelli, MD, Renato Talamini, ScD, Emanuela Vaccher, MD, Umberto Tirelli, MD

Blood (2005) 106 (11): 1436.

https://doi.org/10.1182/blood.V106.11.1436.1436

Published: 2005

Journal Articles

Hodgkin’s Disease and HIV Infection (HD-HIV) in Pre- and Post-HAART Era: The GICAT (Italian Cooperative Group on AIDS and Tumors) Experience in 139 Patients.

Umberto Tirelli, MD, Emanuela Vaccher, MD, Giuseppe Rossi, MD, Clara Schiantarelli, MD, Marco Fasan, MD, Michele Spina, MD

Blood (2005) 106 (11): 1437.

https://doi.org/10.1182/blood.V106.11.1437.1437

Published: 2005

Journal Articles

Ann Arbor Stage Is the Most Important Predictor of Survival for Refractory and Relapsed HIV-Associated Lymphoma Enrolled in a Program of High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation.

Alessandro Re, MD, Chiara Cattaneo, MD, MariaGrazia Michieli, MD, Salvatore Casari, MD, Michele Spina, MD, Maurizio Rupolo, MD, Bernardino Allione, MD, Piero Ferremi, MD, Arnalda Lanfranchi, PhD, Mauro Mazzuccato, MD, Gianpiero Carosi, MD, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2004) 104 (11): 893.

https://doi.org/10.1182/blood.V104.11.893.893

Published: 2004

Journal Articles

High Dose Therapy (HDCT) with Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma in the Elderly: Feasibility of a Patient-Tailored Treatment Plan.

Maurizio Rupolo, MD, Mariagrazia Michieli, MD, Michele Spina, MD, Daniele Bernardi, MD, Massimiliano Berretta, MD, Annalisa Giacalone, Psic, Umberto Tirelli, MD

Blood (2004) 104 (11): 5216.

https://doi.org/10.1182/blood.V104.11.5216.5216

Published: 2004

Journal Articles

R-DHAOX as Salvage Regimen in Patients (pts) with Relapsed/Resistant Non-Hodgkin[spos]s Lymphoma (NHL).

Maurizio Rupolo, MD, Michele Spina, MD, Mariagrazia Michieli, MD, Massimiliano Berretta, MD, Luciano Abbruzzese, MD, Mario Mazzucato, MD, Valter Gattei, MD, Umberto Tirelli, MD

Blood (2004) 104 (11): 1323.

https://doi.org/10.1182/blood.V104.11.1323.1323

Published: 2004

NARROW

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma at High Risk (aa-IPI 2-3). Mature Results of a Multicenter Prospective Phase II Trial

ARL-IPI - A New Prognostic Score for AIDS-Related Lymphomas in the Rituximab Era

A Pooled Analysis of 1,546 Patients with HIV-Associated Lymphoma: Assessment of Lymphoma-, HIV-, and Treatment-Specific Factors On Clinical Outcomes

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma At High Risk (Aaipi 2–3). an Interim Report of a Multicenter Phase II Trial.

Safety and Activity of Intensive Short-Term Chemoimmunotherapy in HIV-Positive (HIV+) Patients (pts) with Burkitt Lymphoma (BL)

HAART Does Not Improve the Outcome of HIV-Related Multicentric Castleman Disease: Results of a Multicentric Retrospective Study

Comprehensive Geriatric Assessment-Adapted Chemotherapy in Elderly Patients (>70 years) with Diffuse Large B-Cell Non-Hodgkin's Lymphoma (DLBCL): Final Results and Long Term Follow-up.

Pretransplatation PET as Major Prognostic Discriminant in IGEV (ifosfamide, gemcitabine, vinorelbine and prednisone) Treated Patients with Relapsed/Refractory Hodgkin's Lymphoma (HL).

Better Outcome with Tandem High DOSE CHEMOTHERAPY and AUTOLOGOUS STEM CELLS TRANSPLANT IN Relapsed/Refractory HODGKIN LYMPHOMA PATIENTS Which Reached COMPLETE REMISSION AFTER Ifosfamide- Gemcitabine-Vinorelbine Scheme (IGEV).

Intensified CHOP (ICHOP) +/− Rituximab in Primary Mediastinal Diffuse Large B Cell Lymphoma (PMBCL): The Role of Doxorubicin/Cyclophosphamide Dose-Intensity

High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation as Salvage Therapy for HIV-Associated Lymphoma: Result of the GICAT Study.

Factors Affecting Outcome of Patients with Refractory/Relapsed Hodgkin’s Disease (HD) Treated with IGEV Chemotherapy (CT) and High Dose Consolidation Therapy (HDT) with Stem Cell Rescue.

Tymic Output after Autologous Bone Marrow Transplantation (ASCT) HIV-Related Lymphoma.

VEBEP Regimen and Highly Active Antiretroviral Therapy (HAART) in Patients (pts) with HD and HIV Infection (HD-HIV).

HIV-Related Burkitt’s NHL (BL) vs. Diffuse Large-Cell NHL (DLCL) in the Pre- and HAART Eras: Significant Differences in Survival with Standard Chemotherapy.

Hodgkin’s Disease and HIV Infection (HD-HIV) in Pre- and Post-HAART Era: The GICAT (Italian Cooperative Group on AIDS and Tumors) Experience in 139 Patients.

Ann Arbor Stage Is the Most Important Predictor of Survival for Refractory and Relapsed HIV-Associated Lymphoma Enrolled in a Program of High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation.

High Dose Therapy (HDCT) with Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma in the Elderly: Feasibility of a Patient-Tailored Treatment Plan.

R-DHAOX as Salvage Regimen in Patients (pts) with Relapsed/Resistant Non-Hodgkin[spos]s Lymphoma (NHL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only